KinDex Pharmaceuticals, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2009-01-01
- Employees
- 1
- Market Cap
- -
Effects of KDT501 on Metabolic Features in Insulin Resistant Subjects
- First Posted Date
- 2015-05-15
- Last Posted Date
- 2017-10-20
- Lead Sponsor
- KinDex Pharmaceuticals, Inc.
- Target Recruit Count
- 9
- Registration Number
- NCT02444910
- Locations
- 🇺🇸
University of Kentucky's Center for Clinical and Translational Science (CCTS), Lexington, Kentucky, United States
© Copyright 2025. All Rights Reserved by MedPath